Navigation Links
Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary
Date:7/10/2008

ere less likely to be colonized by the bacteria in the mucosa of the terminal rectum at harvest (OR=0.014, p<0.0001), resulting in a vaccine colonization efficacy of 98.3%. A two-dose vaccination was used to evaluate hide contamination in the feedlot. Hides were sampled for E. coli O157:H7 contamination twice in the feedlot and immediately before and after animals were shipped to the abattoir. This same study also found a statistically significant reduction in the likelihood of vaccinated animals having contaminated hides. Additionally, pen-level prevalence following a two dose vaccination was assessed in a feedlot study. Vaccinated pens were less likely than unvaccinated pens to test positive (OR=0.59, p<0.004) using the ROPES method.

"These results provide compelling evidence that vaccination of cattle with the Bioniche E. coli O157:H7 cattle vaccine has the potential to be an effective pre-slaughter intervention for the reduction of E. coli O157:H7 shedding, colonization, hide contamination, and pen-level prevalence," concluded Dr. Rogan.

Food recalls due to E. coli O157:H7 contamination continue to be a concern in beef, produce and prepared food. On-farm interventions to reduce the shedding of E. coli O157:H7 by cattle, such as vaccination, may assist in reducing the potential for food and water contamination and the resulting human illnesses and deaths.

Approximately 100,000 cases of human infection with the E. coli O157:H7 organism are reported each year in North America. 2% to 7% of those people develop hemolytic uremic syndrome (HUS), a disease characterized by kidney failure (in recent outbreaks, this percentage has risen to as high as 16%). Five percent of HUS patients die, many of them children and senior citizens, whose kidneys are more sensitive to damage.

In addition to being infected by contaminated food or water, individuals can become infected from E. coli O157:H7 by visiting animal exhibits. Petting zoos, fairs, and agri
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference
2. Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production
3. Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia
4. Bioniche Presents Pre-Clinical Research at Two International Conferences
5. Bioniche Updates re: Mycobacterial Cell Wall Technology Platform
6. Bioniche Reports Fiscal 2008 Third Quarter
7. Bioniche Appoints U.S. President of Food Safety
8. Bioniche Reports the Passing of its Board Chair
9. Bioniche Converts a Portion of its Debt to Equity
10. Bioniche Receives Fast Track Designation For First-Line Bladder Cancer Therapy
11. Bioniche Pharma Chooses TrackWise for its Deviation Control Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... chronic inflammation in non-cancerous prostate tissue may have nearly ... those with no inflammation, according to results of a ... Kimmel Cancer Center. , The link between persistent inflammation ... high-grade prostate cancer those with a Gleason score ... the most aggressive and rapidly growing prostate cancers. , ...
(Date:4/17/2014)... Biology and Medicine a multidisciplinary research team ... in the Institute of Genomic Biology (IGB) on ... describe their recent work on subcellular redox homeostasis. ... functions including energy metabolism, signaling, and transcriptional processes. ... cellular behavior, redox status has been recognized as ...
(Date:4/17/2014)... A Northwestern University synthetic biology team has created ... create programmable therapeutics that could travel the body ... disease. , Engineering cell-based, biological devices that monitor ... in clinical synthetic biology. However, no existing technology ... a patient,s physiological state and respond in a ...
(Date:4/17/2014)... about one in five infants in the United States ... first several months after birth. Research into probiotic use ... the April 1, 2014 issue of the British ... study, "Probiotics and Infant Colic," concluding that the use ... colic did not reduce crying or fussing in ...
(Date:4/17/2014)... potential to ward off depression among retirees, particularly among ... in The Journals of Gerontology, Series B: ... article " Internet Use and Depression Among Retired Older ... the authors report that Internet use reduced the probability ... study sample. , Late-life depression affects between 5 ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Building 'smart' cell-based therapies 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:Internet use may cut retirees' depression 2
... Variations in Therapy Regimens, with Monotherapy Most Common in Elderly ... , ORLANDO, Fla., June 1 There are striking differences ... based on both age and geography, according to a new ... as a poster on Saturday at the 2009 ASCO (American ...
... ties to convicted lobbyist Jack Abramoff , , ... new investigative report today called "Viewers Beware of Anti-Health Care ... in eight states, including Montana, to oppose health care reform. ... Foundation, which has a record as a right-wing political operation ...
... , Group led by conservative political operative with ties to ... Public Campaign Action Fund issued a new investigative report ... the group behind the political ads running in eight states, ... funded by the Americans for Prosperity Foundation, which has a ...
... with ties to convicted lobbyist Jack Abramoff , , ... new investigative report today called "Viewers Beware of Anti-Health Care ... in eight states, including South Dakota, to oppose health care ... Foundation, which has a record as a right-wing political operation ...
... some also suffer PTSD years after treatment , MONDAY, ... aren,t following recommended guidelines on screenings for second cancers ... from post-traumatic stress disorder years after beating their disease, ... can be costly because childhood cancer survivors are more ...
... the Link between Healthy Living and Reducing Health Risks , ... -- Ten year olds aren,t typically at risk ... lead to stroke risk factors. A program run by Sacred ... a healthy lifestyle. In conjunction with parents and the ...
Cached Medicine News:Health News:New Market Research Study Shows Lung Cancer Treatments Differ Significantly by Both Age and Geography 2Health News:New Market Research Study Shows Lung Cancer Treatments Differ Significantly by Both Age and Geography 3Health News:'Viewers Beware' Report by Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running in Montana 2Health News:"Viewers Beware" Report by Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running in Indiana 2Health News:"Viewers Beware" Report by Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running in South Dakota 2Health News:Many Childhood Cancer Survivors Not Checking for Second Malignancies 2Health News:Many Childhood Cancer Survivors Not Checking for Second Malignancies 3Health News:Sacred Heart Hospital Starts to Expose Students to Stroke Awareness at an Early Age 2
(Date:1/15/2014)... 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ECTE ... CGM System as a non-invasive, wireless continuous glucose monitoring ... Executive Chairman and Interim CEO of Echo Therapeutics, will ... Equity Conference. Mr. Doman will make ...
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: Insulin Pump ... http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining strong acceptance ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... research report is available in its catalogue: ... Technologies for Advanced Drug Delivery Systems -- ... http://www.reportlinker.com/p01940411/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-End-Users.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology STUDY OBJECTIVES ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: